Similar companies
| Company | Transaction Value | |
|---|---|---|
 |
OcugenOCGN |
$78,000 |
 |
AmarinAMRN |
$410,000 |
 |
Gilead SciencesGILD |
-$1.03B |
 |
Anavex Life SciencesAVXL |
-$6.3M |
 |
AmgenAMGN |
-$98M |
Insider Transactions
| Name | Transaction Date | Sold / Bought | Shares | Price | Value |
|---|---|---|---|---|---|
| Montgomery Alan Bruce | Jun 16, 2025 | Sell | 2,215 | $9.22 | $20,000 |
| GUSTAFSON KURT A | Jun 16, 2025 | Sell | 2,993 | $9.22 | $28,000 |
| GORMAN KEVIN CHARLES | Jun 16, 2025 | Sell | 3,173 | $9.22 | $29,000 |
| Feigal Ellen | Jun 16, 2025 | Sell | 2,993 | $9.22 | $28,000 |
| RANIERI RICHARD J | Jun 16, 2025 | Sell | 2,993 | $9.22 | $28,000 |
| Valente Nancy | May 2, 2025 | Sell | 4,616 | $11.03 | $51,000 |
| Cornelissen Bart Jan | Apr 10, 2025 | Sell | 3,750 | $8.0621 | $30,000 |
| Dahiyat Bassil I | Mar 10, 2025 | Sell | 19,716 | $13.5971 | $270,000 |
| Valente Nancy | Mar 10, 2025 | Sell | 2,565 | $13.5971 | $35,000 |
| Eckert Celia | Mar 10, 2025 | Sell | 5,740 | $13.5971 | $78,000 |
| Desjarlais John R | Mar 10, 2025 | Sell | 9,697 | $13.5971 | $130,000 |
| Montgomery Alan Bruce | Dec 4, 2024 | Sell | 1,421 | $27.0276 | $38,000 |
| Montgomery Alan Bruce | Dec 2, 2024 | Sell | 13,301 | $27.0299 | $360,000 |
| Dahiyat Bassil I | Nov 21, 2024 | Sell | 49,278 | $24.0749 | $1.2M |
| Dahiyat Bassil I | Nov 13, 2024 | Sell | 3,366 | $24.0172 | $81,000 |
| Desjarlais John R | Nov 11, 2024 | Sell | 68,684 | $23.4791 | $1.6M |
| ROSA-BJORKESON DAGMAR | Sep 27, 2024 | Sell | 2,503 | $20.68 | $52,000 |
| RANIERI RICHARD J | Sep 27, 2024 | Sell | 2,503 | $20.68 | $52,000 |
| GUSTAFSON KURT A | Sep 27, 2024 | Sell | 2,503 | $20.68 | $52,000 |
| GORMAN KEVIN CHARLES | Sep 27, 2024 | Sell | 2,654 | $20.68 | $55,000 |
| Montgomery Alan Bruce | Sep 27, 2024 | Sell | 1,853 | $20.68 | $38,000 |
| Feigal Ellen | Sep 27, 2024 | Sell | 2,503 | $20.68 | $52,000 |
| Desjarlais John R | Jul 9, 2024 | Sell | 36,329 | $18.319 | $670,000 |
| Valente Nancy | May 2, 2024 | Sell | 4,745 | $23.5768 | $110,000 |
| Desjarlais John R | Mar 11, 2024 | Sell | 1,280 | $23.5018 | $30,000 |
| Dahiyat Bassil I | Mar 11, 2024 | Sell | 2,741 | $23.5018 | $64,000 |
| Kuch John J | Mar 11, 2024 | Sell | 849 | $23.5018 | $20,000 |
| Eckert Celia | Mar 11, 2024 | Sell | 850 | $23.5018 | $20,000 |
| GUSTAFSON KURT A | Mar 6, 2024 | Sell | 14,000 | $23.1752 | $320,000 |
| Dahiyat Bassil I | Mar 5, 2024 | Sell | 12,528 | $23.429 | $290,000 |
| Kuch John J | Mar 5, 2024 | Sell | 4,474 | $23.429 | $100,000 |
| Desjarlais John R | Mar 5, 2024 | Sell | 6,629 | $23.429 | $160,000 |
| Eckert Celia | Mar 5, 2024 | Sell | 3,892 | $23.429 | $91,000 |
| Desjarlais John R | Feb 13, 2024 | Sell | 54,108 | $19.3824 | $1M |
| GORMAN KEVIN CHARLES | Feb 13, 2024 | Buy | 53 | $19.12 | $1,000 |
| Dahiyat Bassil I | Dec 29, 2023 | Sell | 45,000 | $20.926 | $940,000 |
What's the latest insider transaction for Xencor?
The most recent insider transaction for Xencor was conducted by Montgomery Alan Bruce, who sold 2,215 shares on June 16, 2025 at a price of $9.22 per share.
Which insider bought the most XNCR stock over the last two years?
GORMAN KEVIN CHARLES has bought the most XNCR stock in the last 2 years, with a total value of $1,000.
Which insider has sold the most XNCR stock over the last two years?
Desjarlais John R has sold the most XNCR stock in the last 2 years, with a total value of $3.6M.
What is the total value of insider transactions for Xencor (XNCR) in the last 2 years?
The total value of insider transactions for Xencor in the last 2 years is negative, amounting to -$8.2M. This suggests that insiders have predominantly sold shares, which could reflect various personal or financial considerations rather than a straightforward outlook on the company's future performance.
How do insider transactions over the last 2 years reflect on Xencor's market confidence?
Over the last 2 years, insider transactions for Xencor have largely consisted of selling shares, which could suggest various personal or financial motivations among insiders. The higher number of sales might require investors to investigate further, considering insiders might have insights or reasons not immediately apparent to the public.
Why is monitoring insider trading activity important for investors?
Monitoring insider trading activity is important because it provides insights into the confidence levels of a company's insiders, such as executives and directors, regarding the company's future prospects. Insider buying can signal optimism, suggesting the stock may be undervalued, while insider selling might raise questions about the stock's upcoming performance. However, it's essential to consider that sales can also occur for personal financial reasons. Insider trading activity is a valuable indicator that, when combined with other data, can help inform investment decisions.
